scholarly journals Dynamics of chest wall volume regulation during constant work rate exercise in patients with chronic obstructive pulmonary disease

Author(s):  
L.S. Takara ◽  
T.M. Cunha ◽  
P. Barbosa ◽  
M.K. Rodrigues ◽  
M.F. Oliveira ◽  
...  
2006 ◽  
Vol 101 (4) ◽  
pp. 1025-1035 ◽  
Author(s):  
Denis E. O’Donnell ◽  
Alan L. Hamilton ◽  
Katherine A. Webb

During constant-work-rate exercise in chronic obstructive pulmonary disease, dyspnea increases steeply once inspiratory reserve volume (IRV) falls to a critical level that prevents further expansion of tidal volume (Vt). We studied the effects of this mechanical restriction on the quality and intensity of exertional dyspnea and examined the impact of an anticholinergic bronchodilator. In a randomized, double-blind, crossover study, 18 patients with chronic obstructive pulmonary disease (forced expiratory volume in 1 s = 40 ± 3%predicted; mean ± SE) inhaled tiotropium 18 μg or placebo once daily for 7–10 days each. Pulmonary function tests and symptom-limited cycle exercise at 75% of each patient’s maximal work capacity were performed 2 h after dosing. Dyspnea intensity (Borg scale), operating lung volumes, breathing pattern, and esophageal pressure ( n = 11) were measured during exercise. Dynamic hyperinflation reached its maximal value early in exercise and was associated with only mild increases in dyspnea intensity and the effort-displacement ratio, which is defined as the ratio between tidal swings of esophageal pressure (expressed relative to maximum inspiratory pressure) and Vt (expressed relative to predicted vital capacity). After a minimal IRV of 0.5 ± 0.1 liter was reached, both dyspnea and the effort-displacement ratio rose steeply until an intolerable level was reached. Tiotropium did not alter dyspnea-IRV relationships, but the increase in resting and exercise inspiratory capacity was associated with an improved effort-displacement ratio throughout exercise. Once a critically low IRV was reached during exercise, dyspnea rose with the disparity between respiratory effort and the Vt response. Changes in dyspnea intensity after tiotropium were positively correlated with changes in this index of neuromechanical coupling.


2018 ◽  
Vol 12 ◽  
pp. 175346581875509 ◽  
Author(s):  
François Maltais ◽  
Denis O’Donnell ◽  
Juan Bautista Gáldiz Iturri ◽  
Anne-Marie Kirsten ◽  
Dave Singh ◽  
...  

Background: The TORRACTO® study evaluated the effects of tiotropium/olodaterol versus placebo on endurance time during constant work-rate cycling and constant speed shuttle walking in patients with chronic obstructive pulmonary disease (COPD) after 12 weeks of treatment. Methods: The effects of once-daily tiotropium/olodaterol (2.5/5 and 5/5 μg) on endurance time during constant work-rate cycle ergometry (CWRCE) after 6 and 12 weeks of treatment were compared with placebo in patients with COPD in a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Endurance time during the endurance shuttle walk test (ESWT) after 6 and 12 weeks of treatment was also evaluated in a subset of patients. Results: A total of 404 patients received treatment, with 165 participating in the ESWT substudy. A statistically significant improvement in endurance time during CWRCE was observed after 12 weeks (primary endpoint) with tiotropium/olodaterol 5/5 µg [14% ( p = 0.02)] but not with tiotropium/olodaterol 2.5/5 µg [9% ( p = 0.14)] versus placebo. In the ESWT substudy, a trend to improvement in endurance time during ESWT after 12 weeks (key secondary endpoint) was observed with tiotropium/olodaterol 5/5 µg [21% ( p = 0.055)] and tiotropium/olodaterol 2.5/5 µg [21% ( p = 0.056)] versus placebo. Conclusion: Tiotropium/olodaterol 5/5 µg improved endurance time during cycle ergometry versus placebo, with a strong tendency to also improve walking endurance time. [ ClinicalTrials.gov identifier: NCT01525615.]


2002 ◽  
Vol 130 (3) ◽  
pp. 305-316 ◽  
Author(s):  
Toshihide Fujie ◽  
Naoko Tojo ◽  
Naohiko Inase ◽  
Nobuo Nara ◽  
Ikuo Homma ◽  
...  

2012 ◽  
Vol 112 (6) ◽  
pp. 1041-1048 ◽  
Author(s):  
Gwenael Layec ◽  
Luke J. Haseler ◽  
Russell S. Richardson

To better understand the metabolic implications of a higher ATP cost of contraction in chronic obstructive pulmonary disease (COPD), we used 31P-magnetic resonance spectroscopy (31P-MRS) to examine muscle energetics and pH in response to graded exercise. Specifically, in six patients and six well-matched healthy controls, we determined the intracellular threshold for pH (TpH) and inorganic phosphate-to-phosphocreatine ratio (TPi/PCr) during progressive dynamic plantar flexion exercise with work rate expressed as both absolute and relative intensity. Patients with COPD displayed a lower peak power output (WRmax) compared with controls (controls 25 ± 4 W, COPD 15 ± 5 W, P = 0.01) while end-exercise pH (controls 6.79 ± 0.15, COPD 6.76 ± 0.21, P = 0.87) and PCr consumption (controls 82 ± 10%, COPD 70 ± 18%, P = 0.26) were similar between groups. Both TpH and TPi/PCr occurred at a significantly lower absolute work rate in patients with COPD compared with controls (controls: 14.7 ± 2.4 W for TpH and 15.3 ± 2.4 W for TPi/PCr; COPD: 9.7 ± 4.5 W for TpH and 10.0 ± 4.6 W for TPi/PCr, P < 0.05), but these thresholds occurred at the same percentage of WRmax (controls: 63 ± 11% WRmax for TpH and 67 ± 18% WRmax for TPi/PCr; COPD: 59 ± 9% WRmax for TpH and 61 ± 12% WRmax for TPi/PCr, P > 0.05). Indexes of mitochondrial function, the PCr recovery time constant (controls 42 ± 7 s, COPD 45 ± 11 s, P = 0.66) and the PCr resynthesis rate (controls 105 ± 21%/min, COPD 91 ± 31%/min, P = 0.43) were similar between groups. In combination, these results reveal that when energy demand is normalized to WRmax, as a consequence of higher ATP cost of contraction, patients with COPD display the same metabolic pattern as healthy subjects, suggesting that skeletal muscle energy production is well preserved in these patients.


Sign in / Sign up

Export Citation Format

Share Document